(excluding I68.0), I69, G45 (excluding G45.3), G46 Ischaemic heart 15-64 years: No -0.1% (-0.7 to 0.4%) n/a n/a n/a No CRF disease effect. per 10 recommended. µg/m3 65+years: No effect. () () 8-hour average No effect in the Meta-analysis of 4 No evidence of EPHC study (), cities - Brisbane, publication bias. Simpson study () Melbourne, Perth, CRF not intended and in COMEAP Sydney for health risk study (). Low heterogeneity assessment ICD9: 410-413 purposes. ICD10: 120-122, 124, 125.2 No effect. () Pooled estimate from 4 cities - Sydney, Brisbane, Melbourne, Perth. All ages and 65+ years. Arrhythmia 15-64 years: No n/a n/a n/a n/a No CRF effect. recommended. 65+ years: No effect. No effect in the () EPHC study (). 1-hour maximum. Lag 01. Meta-analysis of 4
(excluding I68.0), I69, G45 (excluding G45.3), G46 Ischaemic heart disease 15-64 years: No effect. 65+years: No effect. () Meta-analysis of 4 cities - Brisbane, Melbourne, Perth, Sydney Low heterogeneity ICD9: 410-413 ICD10: 120-122, 124, 125.2 No effect. () Pooled estimate from 4 cities - Sydney, Brisbane, Melbourne, Perth. All ages and 65+ years. -0.1% (-0.7 to 0.4%) per 10 µg/m3 () 8-hour average No evidence of publication bias. CRF not intended for health risk assessment purposes. n/a n/a n/a No CRF recommended. No effect in the EPHC study (), Simpson study () and in COMEAP study (). Arrhythmia 15-64 years: No effect. 65+ years: No effect. () 1-hour maximum. Lag 01. Meta-analysis of 4 n/a n/a n/a n/a No CRF recommended. No effect in the EPHC study ().